These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 779447)

  • 21. Comparative biotyping, bacteriocin typing, and serogrouping (O-antigens) of Serratia liquefaciens.
    Traub WH
    Zentralbl Bakteriol; 1991 Jun; 275(2):200-10. PubMed ID: 1718303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological markers of Serratia marcescens isolates causing nosocomial infections in Spain (1981-1991).
    Boquete T; Vindel A; Martin-Bourgon C; Azañedo L; Sáez-Nieto JA
    Microbiologia; 1996 Dec; 12(4):607-12. PubMed ID: 9018695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on serotyping, phage typing and drug resistance of Serratia marcescens isolated from clinical specimens (author's transl)].
    Morishita H
    Nihon Hinyokika Gakkai Zasshi; 1980 Nov; 71(11):1313-27. PubMed ID: 7007698
    [No Abstract]   [Full Text] [Related]  

  • 24. Serratia marcescens: use of detailed characterization of strains to evaluate an increase of isolates in an intensive care unit.
    Cardos SF; Florman AL; Simberkoff MS; Lanier L
    Am J Med Sci; 1973 Dec; 266(6):447-52. PubMed ID: 4590096
    [No Abstract]   [Full Text] [Related]  

  • 25. [Sero-types and drug sensitivity of Serratia marcescens isolated from pathological specimens, with special reference to hospital infections. II. (author's transl)].
    Yama H; Yamada K; Tsujimoto T
    Jpn J Antibiot; 1979 Jun; 32(6):661-7. PubMed ID: 381707
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of Serratia outbreaks in hospital.
    Farmer JJ; Davis BR; Hickman FW; Presley DB; Bodey GP; Negut M; Bobo RA
    Lancet; 1976 Aug; 2(7983):455-9. PubMed ID: 73753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of biotyping and electrophoretic patterns of esterases for differentiation of nosocomial Serratia marcescens strains.
    Chetoui H; Delhalle E; Osterrieth P; Rousseaux D
    Res Microbiol; 1995 Sep; 146(7):579-86. PubMed ID: 8577999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epidemiological evaluation of Serratia marcescens isolates in one Japanese hospital during the two years from April 1997 to March 1999].
    Marumo K; Nakamura Y; Togashi M
    Rinsho Byori; 2000 Oct; 48(10):960-5. PubMed ID: 11215111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic-resistant Serratia marcescens infection in a hospital.
    Ambrosio RE; Van Wyk AJ; De Klerk HC
    S Afr Med J; 1979 Apr; 55(15):584-7. PubMed ID: 380020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serratia: opportunistic pathogen of increasing clinical importance.
    Kwitko AO; Hamra LK; Atkinson JM
    Med J Aust; 1977 Jul; 2(4):119-21. PubMed ID: 331049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two methods for bacteriocin typing of Serratia marcescens.
    Lai PS; Ngeow YF; Puthucheary SD; Wang CW
    J Clin Microbiol; 1983 Jan; 17(1):1-6. PubMed ID: 6338029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endemic Serratia marcescens in the Veterans Administration Hospital in Pittsburgh, Pa., 1971--1976.
    Brown A; Davis L; Yee RB; Postic B
    Health Lab Sci; 1978 Jul; 15(3):159-67. PubMed ID: 359506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotyping of Serratia marcescens strains of clinical origin.
    Coria-Jiménez R; Ortiz-Torres C; Cruz-Camarillo R
    Rev Latinoam Microbiol; 1992; 34(4):253-8. PubMed ID: 1345114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of Grimont biotyping system for epidemiologic studies with nosocomial Serratia marcescens isolates.
    Sifuentes-Osornio J; Gröschel DH
    J Clin Microbiol; 1987 Mar; 25(3):567-8. PubMed ID: 3553228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of a biotyping system and DNA restriction fragment analysis to the study of Serratia marcescens from hospitalized patients.
    Bale M; Sanford M; Hollis R; Pfaller MA
    Diagn Microbiol Infect Dis; 1993 Jan; 16(1):1-7. PubMed ID: 8381062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serratia marcescens causing hospital-acquired lower respiratory tract infection.
    Byrne AH; Boyle B; Herra CM; Hone R; Keane CT
    J Hosp Infect; 2000 Jul; 45(3):242-4. PubMed ID: 10896806
    [No Abstract]   [Full Text] [Related]  

  • 37. Journal of Infection Control Nursing. Serratia marcescens in a special care baby unit.
    Viggars S
    Nurs Times; 1984 Feb 15-21; 80(7):56-9. PubMed ID: 6366752
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidemiology and susceptibility of serratia marcescens in a large general hospital over an 8-year period.
    Hejazi A; Aucken HM; Falkiner FR
    J Hosp Infect; 2000 May; 45(1):42-6. PubMed ID: 10833342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriocin (Marcescin) typing of clinical isolates of Serratia marcescens.
    Traub WH; Raymond EA; Startsman TS
    Appl Microbiol; 1971 May; 21(5):837-40. PubMed ID: 4930037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on group A (phage tail) bacteriocins of Serratia marcescens. V. Serological characterization of subgroup I and II bacteriocins.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1976 May; 234(4):521-7. PubMed ID: 779357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.